Abstract
Leishmania are pathogenic protozoa of the order Kinetoplastida and the family Trypanosomatidae, and they are responsible for diseases affecting more than 12 million people a year throughout tropical and sub-tropical regions. Leishmania have a dimorphic life cycle consisting of extracellular promastigotes that multiply and develop within the alimentary tract of their sand fly vectors and intracellular amastigotes that reside and multiply within the phagolysosomal vacuoles of their host macrophages. Depending mainly upon the species of Leishmania, human infection can display a spectrum of clinical manifestation from localized cutaneous involvement to late destruction of mucous membranes to generalized systemic disease with fatal outcome. Distribution of the more than 20 species and sub-species of Leishmania and the diseases they produce are determined by the availability of competent vectors. Phlebotomine sand flies are the only known natural vectors of Leishmania, and of the more than 400 phlebotomine species described, fewer than fifty are known to be involved in the transmission cycle of these parasites. Furthermore, some vectors species are highly restricted to the species of Leishmania that they transmit in nature. This chapter reviews our vector biological studies, which over the last 20 yrs have sought to better understand the natural habitat of Leishmania parasites during their transformation, growth, differentiation, and migration in the alimentary tract of their competent sand fly vectors and the barriers to survival that are encountered in refractory flies. The review emphasizes those of our studies that have sought to define the parasite-derived molecules that permit the development of transmissible infections to proceed. The work will hopefully serve to better inform the search of the Leishmania and sand fly genomes so that a fuller accounting of the molecules controlling parasite-vector interactions can be achieved, with a longer view toward the development of a successful transmission blocking vaccine(s).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sacks D & Kamhawi S (2001). Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis, Annu Rev Microbiol, 55, 453–483
Sacks D L & Perkins P V (1984). Identification of an infective stage of Leishmania promastigotes, Science, 223, 1417–1419
Sacks D L & Perkins PV (1985). Development of infective stage Leishmania promastigotes within phlebotomine sand flies, Am J Trop Med Hyg, 34, 456–459
Sacks D L, Hieny S, & Sher A (1985). Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes, J Immunol, 135, 564–569
Sacks D L & da Silva R P (1987). The generation of infective stage Leishmania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid, J Immunol, 139, 3099–3106
Turco S J & Descoteaux A (1992). The lipophosphoglycan of Leishmania parasites, Annu Rev Microbiol, 46, 65–94
Sacks D L, Brodin T N & Turco S J (1990). Developmental modification of the lipophosphoglycan from Leishmania major promastigotes during metacyclogenesis, Mol Biochem Parasitol, 42, 225–233
Pimenta P F, da Silva R P, Sacks D L & et al (1989). Cell surface nanoanatomy of Leishmania major as revealed by fracture-flip. A surface meshwork of 44 nm fusiform filaments identifies infective developmental stage promastigotes, Eur J Cell Biol, 48, 180–190
Pimenta P F, Saraiva E M & Sacks D L (1991) The comparative fine structure and surface glycoconjugate expression of three life stages of Leishmania major, Exp Parasitol, 72, 191–204
McConville M J, Turco S J, Ferguson M A & et al (1992). Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage, EMBO J, 11, 3593–3600
Franke E D, McGreevy P B, Katz S P & et al (1985). Growth cycle-dependent generation of complement-resistant Leishmania promastigotes, J Immunol, 134, 2713–2718
Puentes S M, Sacks D L, da Silva R P & et al (1998). Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan, J Exp Med, 167, 887–902
Puentes S M, da Silva R P, Sacks D L & et al (1990). Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9, J Immunol, 145, 4311–4316
da Silva R P, Hall B F, Joiner K A & et al (1989). CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages, J Immunol, 143, 617–622
Pimenta P F, Turco S J, McConville M J & et al (1992). Stage-specific adhesion of Leishmania promastigotes to the sandfly midgut, Science, 256, 1812–1815
Kamhawi S, Modi G B Pimenta P F & et al (2000). The vectorial competence of phlebotomus sergenti is specific for Leishmania tropica and is controlled by species-specific, lipophosphoglycan-mediated midgut attachment, Parasitology, 121, 25–33
Sacks D L, Pimenta P F, McConville M J & et al (1995). Stage- specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan, J Exp Med, 181, 685– 697
Butcher B A, Turco S J, Hilty B A & et al (1996). Deficiency in beta1,3-galactosyltransferase of a Leishmania major lipophosphoglycan mutant adversely influences the Leishmania-sand fly interaction, J Biol Chem, 271, 20573–9
Sacks D L, Modi G, Rowton E & et al (2000). The role of phosphoglycans in Leishmania- sand fly interactions, Proc Natl Acad Sci USA, 97, 406–411
Pimenta P F, Saraiva E M, Rowton E & et al (1994). Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycan, Proc Natl Acad Sci USA, 91, 9155–9156
Kamhawi S, Ramalho-Ortigao M, Pham V M & et al (2004). A role for insect galectins in parasite survival, Cell, 119, 329–341
Saraiva E M, Pimenta P F, Brodin T N & et al (1995). Changes in lipophosphoglycan and gene expression associated with the development of Leishmania major in Phlebotomus papatasi, Parasitology, 111, 275–287
Mahoney A B, Sacks D L, Saraiva E & et al (1999). Intra-species and stage-specific polymorphisms in lipophosphoglycan structure control Leishmania donovani- sand fly interactions, Biochemistry, 38, 9813–9823
Lira R, Mendez S, Carrera L & et al (1998). Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease, Exp Parasitol, 89, 331–342
Adler S (1938). Factors determining the behaviour of Leishmania sp. in sandflies, Harefuah, 14, 1–6
Pimenta P F, Modi G B, Pereira S T & et al (1997). A novel role for the peritrophic matrix in protecting Leishmania from the hydrolytic activities of the sand fly midgut, Parasitology, 115, 359–369
Spath G F, Lye L F, Segawa H & et al (2003). Persistence without pathology in phosphoglycan-deficient Leishmania major, Science, 301, 1241–1243
Joshi P B, Kelly B L, Kamhawi S & et al (2002). Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor, Mol Biochem Parasitol, 120, 33–40
Sacks D L, Kenney R T Kreutzer R D & et al (1995). Indian kala-azar caused by Leishmania tropica, Lancet, 345, 959–961
Tonui W K, Ngumbi P M, Mpoke S S & et al (2004). Leishmania major-Phlebotomus duboscqi interactions: inhibition of anti-LPG antibodies and characterisation of two proteins with shared epitopes, East Afr Med J, 81, 97–103
Ivens A C, Peacock C S, Worthey E A & et al (2005). The genome of the kinetoplastid parasite, Leishmania major, Science, 309, 436–442
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Sacks, D. (2010). Molecular Aspects of Parasite – Vector Interactions In Leishmaniasis. In: Georgiev, V. (eds) National Institute of Allergy and Infectious Diseases, NIH. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-512-5_16
Download citation
DOI: https://doi.org/10.1007/978-1-60761-512-5_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-511-8
Online ISBN: 978-1-60761-512-5
eBook Packages: MedicineMedicine (R0)